Previous Article | Next Article ![]()
Journal of Bacteriology, January 2002, p. 525-530, Vol. 184, No. 2
0021-9193/01/$04.00+0 DOI: 10.1128/JB.184.2.525-530.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Melicent C. Peck,2 and Sharon R. Long1,2*
Howard Hughes Medical Institute,1 Department of Biological Sciences, Stanford University, Stanford, California 94305-50202
Received 30 May 2001/ Accepted 9 October 2001
|
|
|---|
|
|
|---|
A number of genetic and biochemical studies suggest that NodD functions as a sensor and/or receptor for plant signals. Using bacterial nod-lacZ fusions as reporters to monitor activity, NodD from different species exhibits sensitivity to specific flavonoid inducers (15, 17, 20, 38). Chimeric protein constructs and mutational studies also suggest the existence of at least two domains: a common one involved in DNA binding and a second one that specifies the spectrum of flavonoid inducers (2, 3, 26, 37). In vitro biochemical studies showed that extracts from bacterial strains expressing NodD bound to a consensus sequence in the promoter region of nod genes that was designated as the nod box (10, 11, 18). Immunoaffinity-purified NodD1 and ion-exchange-purified NodD3 were shown to protect the nod box from nuclease cleavage in footprinting assays (11, 12). While in vivo studies using reporter fusions have shown that NodD1-dependent activation of nod gene expression requires flavonoid inducers, this has not been demonstrated in vitro, nor has direct binding of flavonoids to NodD protein been shown. Thus, the mechanism of NodD-mediated nod gene expression remains unclear.
The GroESL chaperonin system, functioning as a tetradecamer of GroEL and a heptamer of GroES, forms a protein complex that associates with approximately 10% of Escherichia coli cytoplasmic proteins and facilitates folding and unfolding of proteins to their native forms in the presence of Mg2+ and ATP (7, 8, 21). In previous studies, we found that GroESL copurified with NodD1 and NodD3 from S. meliloti (10, 29). Genetic screening for other components involved in NodD-mediated nod gene expression in S. meliloti revealed that a chromosomal copy of groESL is required (29). In addition, the DNA binding activity of NodD in a cell extract decreases in a groESL mutant background (29). Both genetic and biochemical results strongly suggest that the GroESL chaperonin system is involved in the folding and/or assembly of active NodD proteins to facilitate the regulation of nod gene expression. In this study, we investigated the biochemical properties of recombinant NodD1 and NodD3, including the effect of luteolin on the DNA binding activity of NodD1, and the involvement of GroESL in NodD protein folding.
|
|
|---|
Expression of recombinant NodD1 and NodD3 in E. coli.
For coexpression with GroESL, 30-ml overnight cultures of E. coli DH5
harboring either pNodD1-ST and pGroESL or pNodD3-ST and pGroESL (13) were used to inoculate 1 liter of L-broth medium supplemented with 100 µg of ampicillin/ml and 50 µg of chloramphenicol/ml to select for both plasmids. Cultures were incubated at 37°C with shaking until they reached an optical density at 550 nm of 0.5. Isopropyl-ß-D-thiogalactopyranoside (IPTG) was added (final concentration, 0.1 mM) to induce GroESL expression. To induce recombinant NodD expression, anhydrotetracycline (final concentration, 0.2 µg/ml) was added 15 min after IPTG and the cultures were shaken for 3 h at 37°C. Cell pellets were collected by centrifugation, washed with wash buffer (20 mM Tris-HCl [pH 8.0], 20 mM NaCl, 0.05% NP-40), and stored at -80°C. Cells were thawed, resuspended in 15 ml of lysis buffer (50 mM Tris-HCl [pH 8.0], 100 mM NaCl, 0.05% NP-40, 2.0 µg of leupeptin/ml, 2 mM benzamidine, 1 mM dithiothreitol [DTT], 2 mM phenyl-methylsulfonyl fluoride, 3 µg of pepstatin A/ml), and lysed by passage through a BioNeb cell disruptor (Glas-Col) three times and followed by sonication (three times, 12 s each, with intervening 1-min pauses). The soluble-protein fraction was obtained by centrifugation at 20,000 x g for 40 min. Soluble proteins were further fractionated by adding 0.3 g of ultrapure ammonium sulfate (ICN) per ml of extract, incubating on ice at least 1 h, and centrifuging at 17,000 x g and 4°C for 30 min. The resulting protein precipitate was redissolved in 8 ml of buffer W (100 mM Tris-HCl [pH 8.0], 1 mM EDTA, 1 mM DTT) supplemented with 1 mM phenymethylsulfonyl fluoride and clarified by centrifugation for 15 min at 38,000 x g.
Affinity purification of NodD1-ST and NodD3-ST. The recombinant proteins were purified from 1-liter volumes of E. coli cultures by using 2.5- to 3-ml (bed volume) streptavidin-agarose (Sigma) affinity columns as described previously (36, 39). The columns were washed with 5 to 10 column volumes of buffer W prior to use. Avidin (40 µg/ml) was added to ammonium sulfate-fractionated protein for 30 min on ice to block biotinylated proteins. This protein solution was applied to the streptavidin-agarose column, and the column was washed with 12 to 15 column volumes of buffer W to remove nonspecifically bound proteins. Affinity-purified protein was eluted with 5 bed volumes of buffer E (100 mM Tris-HCl [pH 8.0], 1 mM EDTA, 3 mM diaminobiotin). Most of the protein was eluted at 3 to 9 ml, and it was concentrated and exchanged with storage buffer (25 mM Tris-HCl [pH 7.5], 10% glycerol, 1 mM EDTA, 1 mM DTT, 100 mM KCl) by using an Ultrafree-15 filter unit (30K NMWL membrane, Millipore). Samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 12.5% gels, using the Laemmli buffer system (23). Protein sequencing was carried out by Edman degradation at the Protein and Nucleic Acid facility at Stanford University.
SEC-HPLC analysis and sample collection. Size exclusion chromatography (SEC)-high-performance liquid chromatography (HPLC) separations were performed using a Dionex DX500 system equipped with a gradient pump and a variable-wavelength UV-visible light detector interfaced with the Dionex PeakNet program. The affinity-purified NodD1 preparation was injected into a 4.6- by 250-mm Zorbax Bio Series GF-250 column (Hewlett-Packard) equilibrated in the mobile-phase buffer (50 mM Tris-HCl [pH 7.5], 200 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT). Molecular size calibration was performed using Bio-Rad gel filtration standards (catalog no. 151-1901). The desired peaks were collected and concentrated using a Millipore Ultrafree-MC (polysulfone, 30K NMWL membrane) centrifugal filter concentrator.
GroESL incubation and luteolin treatment. In our standard assay, 5 µl of affinity- or SEC-HPLC-purified NodD protein (1 µM purified recombinant NodD protein and 5 to 10 µM associated GroEL) was incubated with the GroESL cycling system (17 µM GroES, 10 mM KCl, 5 mM MgCl2, 2 mM ATP) in a 10-µl reaction volume for various periods of time at room temperature. Luteolin was dissolved in N,N'-dimethyl formamide to make a concentrated stock solution and stored at -20°C. This concentrated stock solution was diluted in TED100 (50 mM Tris-HCl [pH 8.0], 0.5 mM EDTA, 0.5 mM DTT, 100 mM NaCl) to make a working solution with a luteolin concentration that was 10-fold higher than the final concentration used in a given experiment. An appropriate volume of this working solution was added to samples for 2 to 5 min at room temperature.
DNA-protein complex electrophoretic mobility shift assay (EMSA). The ability of purified recombinant NodD proteins to bind to the nodF nod box was monitored by measuring the specific shift in mobility during gel electrophoresis. Treated NodD samples (2 µl) were incubated at room temperature for 10 min with the end-labeled nodF nod box DNA fragment in binding buffer as described previously (10). The gels were dried, and the migration of DNA fragments was visualized and/or quantitated by autoradiography and/or phosphorimaging (Bio-Rad GS-363 system).
|
|
|---|
![]() View larger version (40K): [in a new window] |
FIG. 1. Affinity purification and DNA binding activity of recombinant NodD1 and NodD3. (A) Strep-tag-purified protein preparations were resolved by SDS-PAGE and stained with Coomassie blue R250. Molecular size standards (in kilodaltons) are indicated (MW). (B) EMSA was performed by mixing purified recombinant NodD1 (100 ng) or NodD3 (200 ng) with an end-labeled nodF nod box DNA fragment as described in Materials and Methods. The negative (-) and positive (+) controls show the migration of the DNA fragment in the absence or presence of excess S. meliloti NodD3 (12), respectively. The arrow indicates the single electrophoretically retarded complex.
|
GroESL modulates the DNA binding activity of NodD1. A direct interaction between GroESL and NodD implicates the chaperonin system in the potential regulation of NodD. In other systems, addition of GroESL, K+, Mg2+, and ATP to unfolded proteins has shown that the protein can refold through a series of cycles of dissociations of polypeptide ligands from preformed complexes ((24a). To address this possibility here, a GroESL cycling system, as described in Materials and Methods, was incubated with purified NodD prior to performance of the DNA binding assay. We predicted that by activating the chaperonin system in vitro, some of the NodD that was in a form that was not competent to bind DNA would be correctly folded into an active form and thus made available for DNA binding. As predicted, preincubation of the chaperonin cycling system with NodD3 resulted in a 60% increase in its ability to bind the regulatory nod box sequence (Fig. 2B). To our surprise, however, incubation with the chaperonin cycling system decreased the DNA binding activity of NodD1 (Fig. 2A). This decrease in the binding activity of NodD1 was not due to a lowering of NodD1 protein levels, as determined by examination of Coomassie-stained SDS gels (data not shown).
![]() View larger version (51K): [in a new window] |
FIG. 2. In vitro GroESL chaperonin treatment affects the DNA binding activity of NodD proteins. Purified recombinant NodD1 (A) and NodD3 (B) were preincubated with the GroESL chaperonin cycling system for the indicated time periods prior to EMSA. The samples were then mixed with labeled nod box DNA fragment and incubated an additional 10 min at room temperature before being loaded onto native polyacrylamide gels. Note that chaperonin-dependent cycling is ongoing throughout this second incubation period before electrophoresis commences. As a control, DNA binding activity in the absence of the chaperonin cycling system was measured (-). Autoradiographs were scanned, and the relative amount of shifted complex normalized to the control is indicated at the bottom of each lane.
|
![]() View larger version (37K): [in a new window] |
FIG. 3. Luteolin-stimulated DNA binding activity of NodD1 is dependent on GroESL treatment. (A) EMSA was performed with preparations of NodD1 (left and middle panels) and NodD3 (right panel) in the presence (+) or absence (-) of the GroESL cycling system (GroE) and/or luteolin. The arrow indicates the single electrophoretically retarded complex. (B) Dosage response of luteolin-stimulated DNA binding activity of NodD1. The indicated concentrations of luteolin were added to NodD1 that had been pretreated with the GroESL cycling system prior to EMSA. The bar graph represents the relative amounts of retarded complex based on phosphorimager quantification.
|
NodD1 activity requires the GroESL chaperonin system. As seen in Fig. 2A, Strep-tag-purified NodD1 that had not been treated with the in vitro chaperonin cycling system could still bind the nod box regulatory sequence. Furthermore, the DNA binding activity was not affected by luteolin (Fig. 3A, left panel), but this activity differed from one preparation to another (data not shown). It is possible that this variability reflected differences in proportions of active and inactive NodD1 in the various preparations. Treatment of purified NodD1 with the chaperonin cycling system reduced nod box binding activity, but binding activity was modulated by luteolin in a GroESL-dependent manner (Fig. 3A, middle panel).
To further probe the role of the chaperonin GroESL in producing functional NodD1, we used SEC-HPLC to separate NodD1 complexed with GroEL from other forms of NodD1 in our affinity-purified preparation. As shown in Fig. 4A and B, SEC-HPLC allowed us to isolate a high-molecular-mass (>850-kDa) GroEL-NodD1 complex. This fraction failed to bind the nod box regulatory sequence unless luteolin, GroES, and ATP were added (Fig. 4C). This result clearly demonstrated the direct involvement of the GroESL chaperonin system in the formation of active NodD1. Apparently, NodD1 requires a fully functional GroESL system to develop its ligand-mediated DNA recognition specificity.
![]() View larger version (36K): [in a new window] |
FIG. 4. The GroESL chaperonin system and luteolin are responsible for formation of active NodD1. (A) Affinity-purified NodD1 was further fractionated by SEC-HPLC as described in Materials and Methods. The indicated fraction was collected and concentrated for SDS-PAGE analysis (B) and EMSA experiments (C). The secondary peak at 7.3 min is diaminobiotin (data not shown). Molecular size standards (in kilodaltons) are indicated in panel B (MW). (C) EMSA was performed following treatment with (+) or without (-) GroES, ATP, and/or 10 µM luteolin as indicated. (D) EMSA was similarly conducted with SEC-HPLC-purified NodD3 after treatment with (+) or without (-) GroES, ATP, and/or luteolin. The arrow indicates the single electrophoretically retarded complex.
|
|
|
|---|
Our in vitro results are consistent with previous in vivo assays of reporter gene expression and mRNA abundance (27), which showed a dependence of NodD1 on flavonoids for induction, in contrast to the constitutive activity of NodD3. Since the discovery of the NodD and flavonoid regulatory circuit, the exact role of the flavonoid has been uncertain, and direct specific binding of NodD to flavonoids has not been demonstrated in vitro. It is interesting that other LysR regulatory proteins have been similarly elusive in demonstrating direct binding to coinducers. Here, in a purified system, we showed that luteolin has a specific effect on NodD1. This provides the first in vitro evidence for a luteolin-mediated effect that relates to NodD1 function.
Another dimension of flavonoid signaling, as yet unexplained, relates to inducer structure and specificity. Each plant produces a cocktail of inducers, most of which are flavonoids; inhibitors are also present in seed and root exudates. Distinct flavonoids are found to be optimal for each plant-Rhizobium pair (9, 22, 3032, 40). Examples of inducing compounds include luteolin and methoxychalcone for alfalfa-S. meliloti, 4',7-dihydroxyflavone for clover-Rhizobium leguminosarum bv. trifoli, daidzein and genistein for soybean-Bradyrhizobium japonicum, and eriodictyol and hesperitin for pea and Vicia sativa-R. leguminosarum bv. viciae. It has been shown that switching the nodD allele in a bacterium is sufficient to change the bacterial flavonoid response specificity (17, 38; M. C. Peck and S. R. Long, unpublished data). How flavonoid structural specificity relates to NodD activity is an important subject for future study.
The mechanism by which chaperonins modulate the activity of the NodD transcriptional activators is not clear. It has been shown that the GroESL chaperonin system is also required for the function of Vibrio fischeri LuxR expressed in E. coli (4). In Bacillus subtilis, GroESL modulates the activity of the repressor HrcA and is thus involved in control of the heat shock response in that organism ((26a). An interaction between GroESL and a LysR family regulator other than NodD has not been reported. Moreover, a specific molecular mechanism for the role of GroESL has not been described for any prokaryotic transcription activator. In eukaryotes, however, at least some examples are known, the most obvious one being the role of the heat shock protein complex in the activity of the steroid receptor proteins (reviewed in reference 1). Specifically, the association of steroid aporeceptors with heat shock protein 90 (HSP90) and other heat shock proteins results in an aporeceptor complex. The presence of steroids results in dissociation of the aporeceptor from the HSP90 complex (34). Then, the activated steroid receptors dimerize and regulate nuclear gene expression.
It is possible that in the present case a variation on this behavior occurs in which chaperonin systems are important for the ability of flavones to interact productively with the bacterial regulatory molecule NodD1. We showed in vitro that the presence of luteolin stimulates the DNA binding activity of NodD1 in the presence of GroESL. Intriguingly, peptide homology between NodD and steroid receptors has been suggested (16). Although the role of flavonoids as ligands is still not clear in this system, the simplest model is that flavonoids bind to the folded and released NodD1 and regulate its activity. Alternatively, flavonoid inducers might dissociate the NodD1-GroESL complex and stimulate the dimerization or oligomerization of NodD1, just as steroids do in eukaryotic systems. The NodD system will provide a genetically and biochemically tractable system for the study of chaperonin action in a ligand-dependent prokaryotic gene transcription system.
This work was supported by NIH grant GM 30962 to S.R.L. and by the Howard Hughes Medical Institute.
Present address: Institute of BioAgricultural Sciences, Academia Sinica, Nankang, Taipei, Taiwan 11529, Republic of China. ![]()
|
|
|---|
32, is involved in transcriptional regulation of the Vibrio fischeri luminescence genes in Escherichia coli. J. Bacteriol. 174:51325135.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»